Shandong Luoxin Pharmaceutical Group Stock Co (Shandong Luoxin Pharmaceutical Group Stock Co) YoY Rev. per Sh. Growth : 21.64% (As of Mar. 2017)

View and export this data going back to 2009. Start your Free Trial

What is Shandong Luoxin Pharmaceutical Group Stock Co YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Shandong Luoxin Pharmaceutical Group Stock Co's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2017 was 21.64%.

Shandong Luoxin Pharmaceutical Group Stock Co's Revenue per Share for the three months ended in Mar. 2017 was $2.86.

Shandong Luoxin Pharmaceutical Group Stock Co YoY Rev. per Sh. Growth Historical Data

The historical data trend for Shandong Luoxin Pharmaceutical Group Stock Co's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Luoxin Pharmaceutical Group Stock Co YoY Rev. per Sh. Growth Chart

Shandong Luoxin Pharmaceutical Group Stock Co Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

YoY Rev. per Sh. Growth

Get a 7-Day Free Trial

39.51

16.49

7.35

25.25

6.26

Shandong Luoxin Pharmaceutical Group Stock Co Quarterly Data
	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
YoY Rev. per Sh. Growth	Get a 7-Day Free Trial															15.24	-3.64	5.60	14.02	21.64

Shandong Luoxin Pharmaceutical Group Stock Co YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Shandong Luoxin Pharmaceutical Group Stock Co's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2016 is calculated as:

	YoY Rev. per Sh. Growth (A: Dec. 2016 )
=	(Revenue per Share (A: Dec. 2016 )	-	Revenue per Share (A: Dec. 2015 ))	/	\| Revenue per Share (A: Dec. 2015 ) \|
=	(9.761	-	9.186)	/	\| 9.186 \|
=	6.26 %

Shandong Luoxin Pharmaceutical Group Stock Co's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2017 is calculated as:

	YoY Rev. per Sh. Growth (Q: Mar. 2017 )
=	(Revenue per Share (Q: Mar. 2017 )	-	Revenue per Share (Q: Mar. 2016 ))	/	\| Revenue per Share (Q: Mar. 2016 )) \|
=	(2.861	-	2.352)	/	\| 2.352 \|
=	21.64 %

Shandong Luoxin Pharmaceutical Group Stock Co YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Shandong Luoxin Pharmaceutical Group Stock Co's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Luoxin Pharmaceutical Group Stock Co (Shandong Luoxin Pharmaceutical Group Stock Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Luoxin Pharmaceutical Group Stock Co Ltd (OTCPK:SLUXY) » Definitions » YoY Rev. per Sh. Growth

Traded in Other Exchanges

N/A

Address

Website

http://www.luoxin.cn

Shandong Luoxin Pharmaceutical Group Stock Co Ltd along with its subsidiaries is engaged in the manufacturing and selling of pharmaceutical products. It is involved in the research and development of LXI-15028, a potassium-competitive acid blocker, which is in phase III development for the treatment of reflux esophagitis and other acid-related gastrointestinal diseases; and LXI-15029, an ATP mTOR kinase inhibitor that acts as potent and selective dual inhibitors of mTORC1 and mTORC2 that controls the process of tumor formation and growth. The company mainly operates in the People's Republic of China.

Shandong Luoxin Pharmaceutical Group Stock Co (Shandong Luoxin Pharmaceutical Group Stock Co) Headlines

No Headlines